[go: up one dir, main page]

FR2951639B1 - Utilisation de l'adenosine et/ou de l'un de ses derives comme agent de traitement de la transpiration humaine - Google Patents

Utilisation de l'adenosine et/ou de l'un de ses derives comme agent de traitement de la transpiration humaine

Info

Publication number
FR2951639B1
FR2951639B1 FR0957434A FR0957434A FR2951639B1 FR 2951639 B1 FR2951639 B1 FR 2951639B1 FR 0957434 A FR0957434 A FR 0957434A FR 0957434 A FR0957434 A FR 0957434A FR 2951639 B1 FR2951639 B1 FR 2951639B1
Authority
FR
France
Prior art keywords
adenosine
derivatives
treatment agent
transpiration
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0957434A
Other languages
English (en)
Other versions
FR2951639A1 (fr
Inventor
Maria Dalko
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Priority to FR0957434A priority Critical patent/FR2951639B1/fr
Priority to PCT/EP2010/065183 priority patent/WO2011047982A2/fr
Publication of FR2951639A1 publication Critical patent/FR2951639A1/fr
Application granted granted Critical
Publication of FR2951639B1 publication Critical patent/FR2951639B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/046—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0957434A 2009-10-22 2009-10-22 Utilisation de l'adenosine et/ou de l'un de ses derives comme agent de traitement de la transpiration humaine Expired - Fee Related FR2951639B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR0957434A FR2951639B1 (fr) 2009-10-22 2009-10-22 Utilisation de l'adenosine et/ou de l'un de ses derives comme agent de traitement de la transpiration humaine
PCT/EP2010/065183 WO2011047982A2 (fr) 2009-10-22 2010-10-11 Utilisation d'adénosine et/ou d'un de ses dérivés en tant qu'agent pour le traitement de la transpiration humaine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0957434A FR2951639B1 (fr) 2009-10-22 2009-10-22 Utilisation de l'adenosine et/ou de l'un de ses derives comme agent de traitement de la transpiration humaine

Publications (2)

Publication Number Publication Date
FR2951639A1 FR2951639A1 (fr) 2011-04-29
FR2951639B1 true FR2951639B1 (fr) 2011-11-04

Family

ID=42358103

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0957434A Expired - Fee Related FR2951639B1 (fr) 2009-10-22 2009-10-22 Utilisation de l'adenosine et/ou de l'un de ses derives comme agent de traitement de la transpiration humaine

Country Status (2)

Country Link
FR (1) FR2951639B1 (fr)
WO (1) WO2011047982A2 (fr)

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3792068A (en) 1971-04-02 1974-02-12 Procter & Gamble Dry powder aerosol antiperspirant composition incorporating dry powder antiperspirant active complex and process for its preparation
FR2668080B1 (fr) 1990-10-17 1993-08-13 Seppic Sa Compositions auto-emulsionnables a base d'alcools gras, leur procede de preparation et leur utilisation pour la realisation d'emulsions.
FR2712595B1 (fr) 1993-11-19 1995-12-22 Seppic Sa Un concentré comportant des alkylglycosides et ses utilisations.
US5874069A (en) 1997-01-24 1999-02-23 Colgate-Palmolive Company Cosmetic composition containing silicon-modified amides as thickening agents and method of forming same
US5919441A (en) 1996-04-01 1999-07-06 Colgate-Palmolive Company Cosmetic composition containing thickening agent of siloxane polymer with hydrogen-bonding groups
US5783657A (en) 1996-10-18 1998-07-21 Union Camp Corporation Ester-terminated polyamides of polymerized fatty acids useful in formulating transparent gels in low polarity liquids
FR2756176B1 (fr) 1996-11-26 1998-12-18 Oreal Composition cosmetique comprenant un compose fluore et presentant un confort ameliore
FR2759582A1 (fr) * 1997-02-14 1998-08-21 Oreal Composition deodorante
FR2762317B1 (fr) 1997-04-21 1999-07-09 Seppic Sa Composition a base d'alkylpolyglycosides et d'alcools gras, et ses utilisations
US6051216A (en) 1997-08-01 2000-04-18 Colgate-Palmolive Company Cosmetic composition containing siloxane based polyamides as thickening agents
US5981680A (en) 1998-07-13 1999-11-09 Dow Corning Corporation Method of making siloxane-based polyamides
FR2792190B1 (fr) 1999-04-16 2001-09-28 Sophim Procede de fabrication d'un emollient non gras a base de cires-esters
JP2004515511A (ja) 2000-12-12 2004-05-27 ロレアル ポリマー及び繊維を含む化粧品組成物
WO2002056847A1 (fr) 2001-01-17 2002-07-25 L'oreal Composition cosmetique contenant un polymer et une huile fluoree
AU2003274652A1 (en) 2002-10-23 2004-05-13 Obetherapy Biotechnology Compounds, compositions and methods for modulating fat metabolism
EP1798213A1 (fr) 2005-12-14 2007-06-20 Cognis IP Management GmbH Procédé pour la production d'hydrocarbures
FR2899584B1 (fr) * 2006-04-11 2008-05-16 Oreal Composition cosmetique antirides

Also Published As

Publication number Publication date
WO2011047982A2 (fr) 2011-04-28
FR2951639A1 (fr) 2011-04-29
WO2011047982A3 (fr) 2012-08-16

Similar Documents

Publication Publication Date Title
FR24C1024I1 (fr) Combinaisons du dolutégravir et de la lamivudine destinées au traitement de l'infection au vih
EP2614369A4 (fr) Inhibiteurs de l'ezh2 humaine, et leurs procédés d'utilisation
EP2672927A4 (fr) Occlusion d'appendice auriculaire et traitement de l'arythmie
EP2278999A4 (fr) Préparations auriculaires de traitement de maladies et états otiques
EP1982660A4 (fr) Endoscope de traitement
EP2432476A4 (fr) Procédés de traitement ou de prévention de maladies ophtalmologiques
EP2150105A4 (fr) Systemes et methodes de ex-vivo de soins d'organes par l'utilisation de lactate comme indicateur
FR2920968B1 (fr) Procede cosmetique de traitement esthetique et/ou reparateur de la peau
EP2338519A4 (fr) Agent de traitement d'une myélofibrose
IL226049A0 (en) Composition for use in the prevention and/or treatment of skin conditions and skin diseases
EP2125002A4 (fr) Traitement du cancer de la peau
EP4219760A3 (fr) Procédés, compositions et dispositifs utilisant un microarn pour déterminer des états physiologiques
EP1755584A4 (fr) Traitement de la myopie
EP2898064A4 (fr) Compositions et procédés de traitement et de prévention d'une lésion et d'une maladie d'un tissu
EP2155225A4 (fr) Procédés de traitement des ulcères de la peau
EP2629799A4 (fr) Base topique et compositions contenant un principe actif, et procédés d'amélioration et de traitement de la peau
BRPI0921026A2 (pt) avaliação do sistema circulatório de um indivíduo
BR112013001297A2 (pt) composições farmacêuticas e respectivo uso e método de tratamento de doença ou condição respiratória
EP2557924A4 (fr) Compositions pharmaceutiques dermiques de 1-méthyl-2',6'-pipécoloxylidide et méthode d'utilisation
EP2209458A4 (fr) Compositions de traitement de la peau
EP2206714A4 (fr) Agent destiné à la prévention et/ou au traitement de maladies cutanées
FR2992173B1 (fr) Procece cosmetique d'eclaircissement de la peau et/ou des levres
FR21C1049I2 (fr) Composition pharmaceutique comportant des sels de citrate et de bicarbonate, et son utilisation pour le traitement de la cystinurie
FI20095600L (fi) Koostumus ihosairauksien hoitoa varten
EP2099465A4 (fr) Amélioration apportée par le reishi de l'adhesion et de la differentiation cellulaires progénitrices de tissu humain

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 7

ST Notification of lapse

Effective date: 20170630